rdf:type |
|
lifeskim:mentions |
umls-concept:C0181904,
umls-concept:C0205210,
umls-concept:C0205466,
umls-concept:C0221202,
umls-concept:C0549193,
umls-concept:C0596972,
umls-concept:C0728873,
umls-concept:C0871261,
umls-concept:C1274040,
umls-concept:C1521743,
umls-concept:C1704632,
umls-concept:C1704646,
umls-concept:C1706817,
umls-concept:C1963724,
umls-concept:C2911692
|
pubmed:issue |
2
|
pubmed:dateCreated |
2007-12-21
|
pubmed:abstractText |
A pruritic papular eruption (PPE) is a common skin manifestation observed in 12-46% of persons with HIV infection living in tropical countries.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1473-5571
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
11
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
269-73
|
pubmed:meshHeading |
pubmed-meshheading:18097229-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:18097229-Adult,
pubmed-meshheading:18097229-Anti-Retroviral Agents,
pubmed-meshheading:18097229-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:18097229-Biological Markers,
pubmed-meshheading:18097229-Cohort Studies,
pubmed-meshheading:18097229-Exanthema,
pubmed-meshheading:18097229-Female,
pubmed-meshheading:18097229-HIV-1,
pubmed-meshheading:18097229-Humans,
pubmed-meshheading:18097229-Male,
pubmed-meshheading:18097229-Middle Aged,
pubmed-meshheading:18097229-Pruritus,
pubmed-meshheading:18097229-Questionnaires,
pubmed-meshheading:18097229-Time Factors,
pubmed-meshheading:18097229-Treatment Outcome,
pubmed-meshheading:18097229-Viral Load
|
pubmed:year |
2008
|
pubmed:articleTitle |
Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?
|
pubmed:affiliation |
Infectious Diseases Institute, Kampala, Uganda.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|